Lumexa Imaging Holdings, Inc. filings document the public-company record for a Nasdaq-listed outpatient medical imaging provider. The company’s disclosures cover its common stock, completed initial public offering, registration statement history, stockholder agreements and capital-structure matters.
LMRI regulatory filings include definitive proxy materials for annual meeting votes and governance matters, Form 8-K reports on financial results, Regulation FD updates, executive transition and compensation arrangements, and material financing agreements. Debt-related filings describe the company’s senior secured credit facility, revolving credit arrangements, maturity terms, interest-rate framework and restrictive covenants affecting operating subsidiaries.
Lumexa Imaging Holdings, Inc. director reports beneficial ownership of a stock option covering 22,222 shares of common stock at an exercise price of $18.5 per share, expiring on 12/10/2035.
The option vests in five substantially equal annual installments starting from a vesting commencement date of March 1, 2025, and each installment requires the director to continue serving with the company. The option is held directly.
Lumexa Imaging Holdings, Inc. filed an initial statement of beneficial ownership for Welsh, Carson, Anderson & Stowe–affiliated entities that are identified as both directors and 10% owners. These reporting persons disclose indirect holdings of Lumexa Imaging common stock through Common Units of Lumexa Imaging Equity Holdco, LLC (Holdings LLC), where each nine Common Units represent the right to acquire one share of common stock held by Holdings LLC.
The filing lists multiple blocks of common stock underlying these derivative securities, including 17,646,994 shares attributable to Welsh, Carson, Anderson & Stowe XII, L.P., 3,219,023 shares for Welsh, Carson, Anderson & Stowe XII Cayman, L.P., and 3,267,506 shares for WCAS Co-Invest Holdco, L.P. After Lumexa Imaging’s initial public offering and a 180-day lock-up period, Holdings LLC may distribute its common stock pro rata to remaining equity holders, at which time these indirect interests may be settled into Lumexa Imaging shares in connection with such a distribution.